Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 300.00% vs -53.33% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -0.30% vs 0.00% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 10.17% vs 197.21% in Mar 2024
Compare Balance Sheet Results of Natural Biocon
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.78
4.30
21.48
499.53%
Share Warrants & Outstandings
Total Reserve
6.09
0.27
5.82
2,155.56%
Shareholder's Funds
31.87
4.57
27.30
597.37%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.07
-0.07
-100.00%
Secured Loans
0.00
0.07
-0.07
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.66
0.66
100.00%
Other Long Term Liabilities
0.00
0.62
-0.62
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.04
-0.04
-100.00%
Current Liabilities
Trade Payables
5.47
0.62
4.85
782.26%
Other Current Liabilities
0.75
0.45
0.30
66.67%
Short Term Borrowings
0.28
20.42
-20.14
-98.63%
Short Term Provisions
0.15
1.30
-1.15
-88.46%
Total Current Liabilities
6.65
22.79
-16.14
-70.82%
Total Liabilities
38.52
27.40
11.12
40.58%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.01
6.53
-6.52
-99.85%
Less: Accumulated Depreciation
0.01
4.46
-4.45
-99.78%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
2.07
-2.07
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
3.29
0.00
3.29
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
21.12
0.05
21.07
42,140.00%
Long Term Loans & Advances
7.07
0.13
6.94
5,338.46%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
31.48
2.25
29.23
1,299.11%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.17
8.28
-8.11
-97.95%
Sundry Debtors
5.66
16.39
-10.73
-65.47%
Cash and Bank
0.05
0.02
0.03
150.00%
Other Current Assets
1.17
0.36
0.81
225.00%
Short Term Loans and Advances
0.00
0.09
-0.09
-100.00%
Total Current Assets
7.04
25.15
-18.11
-72.01%
Net Current Assets (Including Current Investments)
0.39
2.36
-1.97
-83.47%
Total Current Assets Excluding Current Investments
7.04
25.15
-18.11
-72.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
38.52
27.40
11.12
40.58%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.28
20.49
-20.21
-98.63%
Book Value per share (adjusted)
12.36
10.63
1.73
16.27%
Annual - Borrowings
Borrowings 0.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 300.00% vs -53.33% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 3.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.30% vs 0.00% in Mar 2024
Annual - Investments
Investments 21.12 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 7.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.17% vs 197.21% in Mar 2024
